Martin Hart alias Dr. Mold & Lyme Chiro

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins. as within their scope of practice.

Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins.

Supports

There is emerging peer-reviewed literature describing Chronic Inflammatory Response Syndrome (CIRS) as an acquired medical condition characterized by innate immune dysregulation following environmental exposure, including mold and other biotoxins, with multi‑system involvement. ^[10] A 2015 transcriptomic study of patients who developed CIRS after ciguatoxin exposure found distinct gene expression patterns separating cases from controls and highlighted disruption of innate and adaptive immune mechanisms, supporting that at least one form of CIRS is a chronic inflammatory, multi‑system response to a specific biotoxin exposure. Recent review articles and case reports (outside the provided index list) describe CIRS related to water‑damaged buildings and mold as a complex, multi‑symptom condition attributed to biotoxins and inflammagens, again supporting that the concept exists in the peer‑reviewed literature as a chronic inflammatory response to molds and other environmental biotoxins. ^[9] Overall, these sources support that a chronic, multi‑system inflammatory syndrome after certain biotoxin exposures has been described and studied, lending some support to the general framing of CIRS as a complex, multi‑system condition triggered by mold and biotoxins.

Contradicts

Major high‑quality evidence sources and guidelines in the provided index list do not address CIRS or “mold illness” at all, which means there is no guideline‑level endorsement of CIRS as a well‑established disease entity. ^[5][9] The hypertension guideline update, ESPEN and ASPEN‑FELANPE nutrition guidelines, parenteral nutrition appropriateness statement, EFNS tension‑type headache guideline, blood transfusion therapy review, pleural effusion diagnostic approach, and GRADE imprecision paper all focus on other conditions and do not recognize or discuss CIRS or mold illness. ^{[1][2][3][4][6][7][8][10]} This absence in major guidelines and methodological standards underscores that the evidence base for CIRS is still limited and not integrated into mainstream clinical frameworks. In addition, available CIRS literature relies heavily on observational data, case series, and single‑center cohorts, often from a small group of proponents, with very few or no independent randomized controlled trials, which weakens the strength of evidence for causality and for the broad claim that CIRS is a well‑defined, common, multi‑system condition from mold and other biotoxins. Some mainstream reviews of indoor air quality and sick building syndrome characterize symptoms after building‑related exposures as multifactorial, with psychological, ergonomic, and general environmental contributors, rather than a single, unified biotoxin‑driven inflammatory syndrome. This body of evidence and the lack of major guideline recognition contradict the strong, categorical framing of mold illness/CIRS as a clearly established complex multi‑system disease with a well‑validated pathophysiology and diagnostic criteria.

Mainstream view

The mainstream medical position is that exposure to dampness and mold can contribute to respiratory symptoms (such as asthma exacerbations, allergic rhinitis, and hypersensitivity pneumonitis) and sometimes to poorly specific symptoms, but that a distinct, universally accepted entity called Chronic Inflammatory Response Syndrome (CIRS) or “mold illness” is not yet established in major clinical guidelines or consensus documents. ^{[2][3][5][9][10]} Conventional allergology, pulmonology, and occupational medicine recognize mold‑related disease primarily in terms of allergic and immunologic conditions with defined diagnostic criteria (IgE‑mediated allergy, hypersensitivity pneumonitis, fungal infections) rather than a single chronic multi‑system inflammatory syndrome driven by biotoxins. Research such as the ciguatoxin‑induced CIRS transcriptomic study supports that chronic inflammatory responses with multi‑system involvement can occur after specific biotoxin exposures and that the term CIRS is used in the scientific literature in that context. However, the broader concept promoted by influencers—that mold and diverse biotoxins commonly cause a unified, well‑characterized syndrome affecting many organ systems and explain a wide range of chronic illnesses—remains controversial. Major bodies have not endorsed standardized diagnostic criteria or treatment protocols for CIRS, and the evidence is considered preliminary, with calls for larger, independent, rigorously designed studies before CIRS can be accepted as a distinct, widely recognized clinical entity. ^[6]

In their own wordsView sourceArchived copy

“Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins.”

Rule: T.C.A. § 63-4-101(a)(1)(B), (D); § 63-4-101(a)(2)

See every doc bro advertising Mold illness and CIRS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection. as within their scope of practice.

Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection.

Supports

Several lines of peer‑reviewed evidence and expert review articles support conceptualizing persistent Lyme-related symptoms (including post-treatment Lyme disease syndrome, PTLDS) as involving maladaptive host responses, immune dysregulation, and nervous system effects rather than always reflecting a single ongoing active infection. Contemporary reviews of PTLDS mechanisms describe proposed drivers such as permanent tissue damage, ongoing inflammation, immune dysfunction, autoimmune responses, co‑infection, and in some cases persistent but treatment‑refractory infection, highlighting that chronic illness can be maintained by host immune and inflammatory processes even after adequate antimicrobial therapy.^[12][18][13] A detailed review on PTLDS pathogenesis in a major clinical journal emphasizes that many patients’ persistent symptoms are better explained by maladaptive host responses and central sensitization (i.e., heightened pain and fatigue signaling that fails to reset), rather than being primarily driven by a continuing active Borrelia infection.^[20][23][15] Immunologic studies in Lyme neuroborreliosis document elevated pro‑inflammatory cytokines and chemokines (e.g., IL‑6, IL‑8, IL‑12, IL‑18, CXCL12, CXCL13) in cerebrospinal fluid, consistent with sustained immune activation and neuroinflammation affecting the nervous system in some patients.^[11][19] Experimental murine models demonstrate Borrelia burgdorferi colonization of the meninges (dura mater) with robust interferon responses and inflammation in the central nervous system, as well as sterile interferon signaling in brain parenchyma, supporting the idea that CNS immune responses and neuroinflammation can persist and contribute to symptoms beyond simple presence of bacteria.^[6][8][10] Clinical and translational work from major Lyme research centers describes persistent symptoms as arising from combinations of chronic inflammation, infection‑induced immune dysfunction or autoimmunity, altered neural pathways (including autonomic and central nervous system changes), persistent bacterial infection or debris, and host genetic or immunologic factors—again framing chronic illness as a multifactorial immune‑nervous system condition rather than solely an ongoing localized infection.^[22][21]

Contradicts

High‑quality guidelines and mainstream reviews emphasize that the primary, evidence‑based model of Lyme disease is an infectious illness caused by Borrelia burgdorferi, for which appropriately timed antibiotic therapy is highly effective at clearing active infection in the vast majority of patients.^[16][13] Large randomized controlled trials of prolonged or repeated antibiotic therapy for patients with chronic symptoms after recommended treatment have generally failed to show meaningful, durable benefit, and have found significant risks, which argues against a simple model where an ongoing active infection is the predominant cause of most persistent Lyme‑related illness; instead, they suggest that continued antimicrobial targeting of active infection is often ineffective for these syndromes (reported in major PTLDS reviews).^[13][18][23] At the same time, mainstream reviews make clear that persistent symptoms are heterogeneous: while immune dysregulation, central sensitization, and neuroinflammation are plausible and supported mechanisms in some patients, evidence remains incomplete and conflicting, and persistent, treatment‑refractory infection or bacterial remnants are also considered viable contributors in a subset of cases.^{[13][18][20][24][21]} Because mechanistic work on immune stress and nervous system disruption in chronic Lyme and PTLDS is still evolving and based largely on observational data, animal models, and small cohorts, the strength of evidence is moderate rather than definitive, and it does not fully justify dismissing persistent active infection as a possible driver in all patients.^{[12][18][20][23]}

Mainstream view

The mainstream medical position is that Lyme disease is fundamentally an infectious disease caused by Borrelia burgdorferi and related species, with well‑characterized early and disseminated stages, and that most patients are cured of active infection with standard, guideline‑recommended antibiotic regimens.^[16][13] For the subset of patients who experience chronic or post‑treatment symptoms (often labeled post-treatment Lyme disease syndrome, PTLDS), major reviews and expert consensus consider multiple, overlapping mechanisms: persistent but hard‑to‑eradicate infection in some cases; infection‑induced immune dysregulation and chronic inflammation; autoimmune phenomena; structural tissue injury; and central nervous system changes such as central sensitization and autonomic dysfunction.^{[12][18][20][21][22][23]} Current evidence supports viewing chronic Lyme‑related illness as a multifactorial condition in which ongoing immune activation and nervous system dysregulation play important roles for many patients, but it does

In their own wordsView sourceArchived copy

“Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection.”

Rule: T.C.A. § 63-4-101(a)(1)(B), (D); § 63-4-101(a)(2)

See every doc bro advertising Lyme disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness..

Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness.

Supports

The indexed papers show that chronic fatigue, gut dysfunction, inflammation, and autoimmunity are recognized, prevalent clinical problems that are commonly managed by clinicians and allied health professionals, which makes it plausible that a physician could work extensively with people who have these conditions. Systematic reviews demonstrate that chronic illness and fatigue in older adults are common and require ongoing clinical management, including rehabilitation and self‑management programs, implying that clinicians routinely care for such patients. A systematic review and meta‑analysis on gut dysbiosis in severe mental illness and chronic fatigue highlights gut dysfunction and chronic fatigue as overlapping, clinically important issues, again supporting that these are legitimate focuses of clinical practice. The chapter on the gut‑immune‑brain axis discusses how inflammation and autoimmunity intersect with gut dysfunction, further supporting that these are standard, evidence‑based clinical domains.

Contradicts

None of the indexed papers evaluate Dr. Hart’s own practice patterns, patient volume, or outcomes, so they do not directly confirm that this specific clinician “works extensively” with these conditions. The available evidence describes disease mechanisms and management strategies for chronic fatigue, inflammation, autoimmunity, and gut dysfunction, but it does not provide data on environmentally driven illness as a distinct, well‑defined diagnostic category, nor does it validate any particular clinician’s claimed expertise or caseload. Overall, the claim about the scope and extent of Dr. Hart’s individual practice is a marketing or biographical statement rather than a directly testable scientific claim, so high‑quality evidence neither strongly supports nor contradicts it.

Mainstream view

Mainstream medical evidence recognizes inflammation, autoimmunity, chronic fatigue, gut dysfunction, and mineral imbalances as important clinical problems that are commonly addressed in primary care, internal medicine, rheumatology, gastroenterology, psychiatry, and rehabilitation settings. Systematic reviews on chronic illness and fatigue in older individuals and on fatigue self‑management confirm that chronic fatigue and related symptoms are prevalent and that structured management approaches are used across health professions. Evidence on the gut‑immune‑brain axis and gut dysbiosis indicates that gut dysfunction can be mechanistically linked to inflammation, autoimmunity, and chronic fatigue, fitting within a mainstream, research‑based framework rather than being fringe concepts. Mainstream practice also acknowledges environmental factors (such as toxins, occupational exposures, and lifestyle) as contributors to disease, but “environmentally driven illness” is not typically used as a single, unified diagnostic label; instead, specific conditions (e.g., asthma from air pollutants, occupational lung disease, heavy‑metal toxicity) are addressed individually.

In their own wordsView sourceArchived copy

“Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness.”

Rule: T.C.A. § 63-4-101(a)(2); § 63-4-101(a)(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure PANS/PANDAS.

PANS/PANDAS

Supports

There are currently no high-quality randomized controlled trials, systematic reviews, or major clinical guidelines showing that chiropractic manipulation or other chiropractic therapies effectively treat PANS or PANDAS. Contemporary consensus guidelines and reviews emphasize three pillars of care: psychiatric/behavioral interventions (e.g., CBT/ERP and psychopharmacology), antimicrobial treatment of streptococcal or other triggering infections, and immunomodulatory therapies in selected cases, with no mention of chiropractic care as a treatment modality.^{[19][21][22][23]} International and consortium guidelines (including PANS/PANDAS consortium documents summarized by NIMH and PANS research groups) likewise focus on antibiotics, immunotherapies such as corticosteroids, IVIG, plasmapheresis, and standard psychiatric care, again without citing chiropractic as a recommended or evidence-based intervention.^{[2][5][11][14][15][19][21][22][23]} Because chiropractic treatment is absent from these evidence-based frameworks, there is no supporting high-quality evidence for its use as a treatment for the underlying autoimmune/inflammatory brain process in PANS/PANDAS.

Contradicts

Evidence-based guidelines and narrative reviews of PANS/PANDAS consistently recommend medical and psychiatric approaches and explicitly note that data for many alternative and adjunctive interventions are limited or lacking.^{[19][21][22][23]} These guidelines describe PANS/PANDAS as postinfectious inflammatory or autoimmune neuropsychiatric syndromes requiring management of infection, neuroinflammation, and psychiatric symptoms; they do not list spinal manipulation or chiropractic techniques among evidence-supported therapies, which indirectly contradicts claims that chiropractic treatment is an established or effective therapy.^[19][22][23] Systematic and consensus discussions emphasize that treatment evidence is already limited even for immunomodulatory therapies such as IVIG and plasmapheresis, with recommendations based largely on small studies and expert opinion, underscoring that modalities with no data—such as chiropractic—should be considered unproven and outside evidence-based practice.^[18][22][23] Major professional and guideline-type documents on pediatric neuroimmune and autoimmune neuropsychiatric syndromes likewise focus on immunology, infectious disease, neurology, and psychiatry, not chiropractic, highlighting the lack of mechanistic or clinical trial support for chiropractic as treatment for PANS/PANDAS.^{[19][21][22][23]}

Mainstream view

The mainstream medical and scientific position is that PANS and PANDAS are complex, often postinfectious inflammatory or autoimmune brain disorders that should be managed with a combination of evidence-based psychiatric/behavioral therapy, appropriate antimicrobial treatment for documented or suspected infections (particularly group A streptococcal infection in PANDAS), and immunomodulatory therapies in carefully selected, more severe or clearly immune-mediated cases.^{[2][5][11][19][21][22][23]} Current consensus guidelines from expert panels and research consortia do not endorse chiropractic treatment as a disease-modifying or primary therapeutic option for PANS/PANDAS; at most, manual therapies might be viewed as nonspecific supportive care if used, but they are not part of guideline-directed management.^{[19][21][22][23]} Mainstream clinicians consider chiropractic treatment for PANS/PANDAS to be unsupported by evidence and potentially misleading if it replaces or delays established medical and psychiatric care, especially given the risks of undertreated infection, neuroinflammation, and severe neuropsychiatric symptoms in affected children.^{[19][21][22][23]}

In their own wordsView sourceArchived copy

“PANS/PANDAS”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising PANS and PANDAS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Hashimoto's thyroiditis.

Hashimoto's thyroiditis

Supports

There are no high-quality randomized trials, systematic reviews, or major clinical guidelines showing that chiropractic spinal manipulation treats Hashimoto’s thyroiditis or alters its autoimmune course. The only directly relevant clinical trial in the chiropractic/manual-therapy literature is a randomized, placebo-controlled, blinded trial of Neuro Emotional Technique (NET) for primary hypothyroidism, which is a chiropractic-associated mind–body intervention rather than standard spinal manipulation; this trial found no statistically significant or clinically relevant benefit on thyroid-related outcomes versus placebo at 7 weeks or 6 months.^[2] Lower-level evidence consists of isolated case reports and case series reporting improved thyroid function or reduced need for levothyroxine after chiropractic care, but these are uncontrolled, highly prone to bias, and do not establish causality. Narrative reviews on spinal manipulative therapy and immune/endocrine effects report that manipulations may transiently influence neuro‑immuno‑endocrine markers, but emphasize that evidence for clinically meaningful immune or endocrine modulation is mixed, conflicting, and limited by small samples and methodological problems.^[15] Overall, there is no robust, guideline-level evidence that chiropractic care is an effective disease‑modifying treatment for Hashimoto’s thyroiditis.

Contradicts

The best available trial evidence in a hypothyroid population shows that a chiropractic-associated intervention (NET) is safe but does not improve thyroid-related outcomes compared with placebo, indicating no therapeutic benefit.^[2] Reviews of spinal manipulative therapy and immune/endocrine responses conclude that while biological effects are plausible, current data are inconsistent, of low quality, and insufficient to justify claims that manipulation meaningfully modulates autoimmune disease activity.^[15] A case report describes a patient with Hashimoto’s disease who developed transient destructive thyrotoxicosis after vigorous physical manipulation/massage of the neck and goiter region, suggesting that aggressive manual therapy around the thyroid in autoimmune thyroiditis can, in rare cases, precipitate harm rather than benefit.^[4] Major guidelines for endocrine and autoimmune disease management, and general evidence-based guideline methodology such as GRADE, stress the need for high-quality trials and do not list chiropractic care as a recommended treatment modality for autoimmune thyroiditis.^[6] The empirical evidence and guideline-based framework therefore contradict the notion that chiropractic treatment is an established or reliable therapy for Hashimoto’s thyroiditis.

Mainstream view

Mainstream endocrinology and internal medicine view Hashimoto’s thyroiditis as an autoimmune destruction of the thyroid gland for which standard care focuses on monitoring thyroid function and treating hypothyroidism with levothyroxine when indicated, sometimes combined with attention to comorbidities and general lifestyle factors; chiropractic care is not recognized as a disease‑modifying treatment for Hashimoto’s thyroiditis and is not included in major clinical practice guidelines for thyroid autoimmune disease. High‑quality evidence required under frameworks such as GRADE shows no proven benefit of chiropractic interventions for thyroid hormone normalization or antibody reduction in Hashimoto’s thyroiditis, and existing data are limited to case reports and one negative randomized trial in hypothyroidism.^[2][6][15] Chiropractic may be used by some patients as an adjunct for musculoskeletal pain, stress, or general well‑being, but the mainstream position is that it should not replace evidence‑based endocrine management and is not recommended as a primary treatment for Hashimoto’s thyroiditis.

In their own wordsView sourceArchived copy

“Hashimoto's thyroiditis”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Thyroid disease and Hashimoto

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure rheumatoid arthritis.

rheumatoid arthritis

Supports

The only supportive evidence I found is weak and indirect: a small 2015 systematic review of non-invasive manual therapy in rheumatoid arthritis reported limited evidence for manipulation, mobilisation, massage, and exercise, and concluded that most such interventions require further high-quality research before confident clinical use. ^{[3][5][7][25][26][28]} Some narrative or low-level sources suggest possible symptom relief, but they do not establish efficacy for rheumatoid arthritis treatment and are not high-quality evidence.

Contradicts

The best available evidence and guidance do not support chiropractic treatment as a rheumatoid arthritis therapy. ^{[6][5][7][25][28]} A 2022 ACR guideline states that using chiropractic therapy is conditionally recommended against, noting the absence of evidence for direct management of RA. ^[1][27] The physiotherapy guideline source also advises against manual cervical spine manipulation in RA because of possible cervical instability, and it states that evidence for passive mobilization is insufficient. A review of chiropractic care for arthritis reports no evidence for rheumatoid arthritis and highlights potential adverse effects. ^[26] The safety concern is especially relevant because cervical spine manipulation can be contraindicated in RA due to atlanto-axial instability.

Mainstream view

Mainstream rheumatology considers chiropractic care, especially spinal manipulation, not to be a disease-modifying or evidence-based treatment for rheumatoid arthritis. ^{[1][25][26][27]} Standard RA care is pharmacologic disease control with DMARDs and, when appropriate, adjunctive exercise/rehabilitation; manual therapy may sometimes be considered only cautiously for symptom relief and not during active inflammation or when cervical instability is present. ^[4][7][28]

In their own wordsView sourceArchived copy

“rheumatoid arthritis”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure lupus.

lupus

Supports

High-quality evidence supports the use of chiropractic spinal manipulation for some types of musculoskeletal neck and low back pain in the general population, not specifically in lupus.^[11] Systematic reviews and RCTs of chiropractic or spinal manipulation show benefit for mechanical pain conditions, but these trials have not evaluated disease activity, organ involvement, or immunologic outcomes in systemic lupus erythematosus (SLE).^[11] In lupus, non-pharmacologic interventions such as structured exercise, lifestyle programs, patient education, psychological counseling, and nutritional approaches have RCTs and guideline support for improving symptoms and quality of life, but chiropractic manipulation itself is absent from this evidence base.^{[1][2][3][9][12][16][19][22][23]}

Contradicts

Evidence reviews of complementary and alternative medicine in SLE specifically note that chiropractic manipulation and massage have not been studied in lupus, and that available evidence for these modalities is lacking.^[10] Major rheumatology guidelines for SLE management from EULAR and the American College of Rheumatology emphasize pharmacologic therapy (hydroxychloroquine, glucocorticoids, immunosuppressants, biologics, and targeted agents) plus general lifestyle and rehabilitation measures, and they do not recommend chiropractic treatment as a disease-modifying or core management strategy.^{[4][5][6][14][17][18][20][21][23]} The EULAR recommendations for non-pharmacologic management of SLE focus on patient education, exercise, smoking cessation, psychological support, and other modalities, and do not include chiropractic care among evidence-based interventions.^{[1][2][3][7][9][12]} Case reports or anecdotal accounts claiming lupus “resolution” after chiropractic care are uncontrolled, subject to spontaneous fluctuation of disease activity, co-interventions, and diagnostic uncertainty, and are not considered reliable evidence for efficacy.^[13][15] Overall, there are no RCTs, systematic reviews, or major guidelines showing that chiropractic treatment can control autoimmune inflammation, prevent flares, protect organs, or replace standard lupus therapies.^{[4][5][6][14][17][18][20][21][23]}

Mainstream view

The mainstream medical and scientific position is that systemic lupus erythematosus is a complex autoimmune disease that requires evidence-based pharmacologic treatment (hydroxychloroquine for nearly all patients, judicious glucocorticoids, immunosuppressive drugs, biologics, and emerging targeted therapies) guided by rheumatology specialists.^{[4][5][6][14][17][18][20][21][23]} Non-pharmacologic care is recommended as an adjunct to improve quality of life and reduce comorbid risk, including structured exercise, lifestyle interventions, education, psychological support, and sometimes nutrition or gut-directed therapies, but these are not substitutes for disease-modifying drugs.^{[1][2][3][7][9][12][16][19][22]} Chiropractic manipulation may have a role similar to other physical or manual therapies in managing non-specific musculoskeletal pain, but it is not recognized as a treatment for the underlying pathophysiology of lupus, nor as a primary or disease-modifying therapy by major rheumatology guidelines.^{[4][5][6][10][11][14]} Patients with SLE are generally advised to use any complementary therapies only as adjuncts, with rheumatologist oversight, and not to discontinue or delay standard evidence-based treatments in favor of chiropractic care.^{[4][5][6][14][23]}

In their own wordsView sourceArchived copy

“lupus”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise I am in remission of Lyme Disease and the above illnesses. as within their scope of practice.

I am in remission of Lyme Disease and the above illnesses.

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“I am in remission of Lyme Disease and the above illnesses.”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

See every doc bro advertising Lyme disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Mold Illness (CIRS).

Mold Illness (CIRS)

Supports

There is currently no high-quality evidence such as randomized controlled trials, systematic reviews, or major clinical guidelines showing that chiropractic spinal manipulation or standard chiropractic care treats mold illness or Chronic Inflammatory Response Syndrome (CIRS). ^{[3][2][5][9][33]} Academic and clinical literature on CIRS focuses on environmental remediation, use of bile acid sequestrants (e. g. , cholestyramine), management of nasal colonization (MARCoNS), correction of specific biomarkers, and sometimes other pharmacologic or mind–body approaches, not chiropractic interventions. Some clinical programs for CIRS are run by chiropractors who apply Shoemaker-style protocols, but this is as functional medicine practitioners using environmental and pharmacologic strategies rather than chiropractic adjustment itself as a primary disease-modifying therapy. ^[7]

Contradicts

Mainstream medical reviews and guidelines on indoor mold exposure and mold-related illness emphasize removal from exposure, remediation of water-damaged buildings, and symptom-directed medical management; they do not list chiropractic treatment as an evidence-based therapy for mold illness or CIRS. ^{[1][3][5][7][33][34][35]} Descriptions of the Shoemaker protocol and related CIRS frameworks consistently center on environmental assessment, binders, targeted pharmacologic interventions, and biomarker-guided care, again without identifying chiropractic manipulation as a validated treatment for the underlying inflammatory process. ^[6][9] Existing evidence for CIRS treatments is itself limited (case series, narrative reviews, single case reports) and often lacks robust RCTs, which further weakens any extrapolation to chiropractic approaches.

Mainstream view

The mainstream medical position is that mold-related illness and CIRS, where recognized, should be managed primarily by eliminating exposure to damp and moldy environments, remediating water-damaged buildings, and providing supportive, evidence-based medical care tailored to specific diagnoses (e. ^{[1][5][9][33][35]} g. , asthma, allergies, infections), as outlined in national and specialty guidelines on indoor mold and environmental health. ^[3] Within this framework, chiropractic care may be used as an adjunct for nonspecific musculoskeletal pain or spinal complaints, but it is not considered a disease-modifying or core treatment for mold illness or CIRS, and no major guideline recommends chiropractic manipulation as a primary therapy for these conditions. ^{[2][6][7][34]}

In their own wordsView sourceArchived copy

“Mold Illness (CIRS)”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Mold illness and CIRS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Lyme Disease.

Lyme Disease

Supports

No high-quality evidence supports chiropractic treatment as a treatment for Lyme disease or tick-borne co-infections. The major evidence-based Lyme guidelines focus on diagnosis, antibiotic treatment, and management of complications, including coinfection with other tick-borne pathogens, and do not recommend chiropractic care as disease treatment. ^{[36][37][38][39]} The mainstream Lyme-disease literature and guideline summaries emphasize validated diagnostic testing and antimicrobial therapy rather than manipulative or structural therapies.

Contradicts

The claim is contradicted by the absence of randomized trials, systematic reviews, or major guidelines showing chiropractic treatment can eradicate Borrelia infection or treat co-infections. ^[38][39] The only index items provided are a Lyme guideline and a guideline summary, both of which describe medical diagnosis and antibiotic treatment, not chiropractic therapy. ^[36][37] Chiropractic websites and testimonials are not peer-reviewed evidence and do not establish efficacy. Evidence for persistent symptoms after treatment exists, but that does not support chiropractic as an anti-infective treatment.

Mainstream view

The mainstream medical view is that Lyme disease and tick-borne co-infections are infectious diseases treated with evidence-based antimicrobial therapy when indicated, plus supportive care for symptoms and complications. ^{[36][37][38][39]} Chiropractic may be used by some patients for nonspecific musculoskeletal pain, but it is not an established or guideline-endorsed treatment for Lyme disease itself or for eradicating co-infections.

In their own wordsView sourceArchived copy

“Lyme Disease”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Lyme disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure MCAS & Histamine Issues.

MCAS & Histamine Issues

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“MCAS & Histamine Issues”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising MCAS and histamine intolerance

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmunity.

Autoimmunity

Supports

The indexed papers show that chronic fatigue, gut dysfunction, inflammation, and autoimmunity are recognized, prevalent clinical problems that are commonly managed by clinicians and allied health professionals, which makes it plausible that a physician could work extensively with people who have these conditions. Systematic reviews demonstrate that chronic illness and fatigue in older adults are common and require ongoing clinical management, including rehabilitation and self‑management programs, implying that clinicians routinely care for such patients. A systematic review and meta‑analysis on gut dysbiosis in severe mental illness and chronic fatigue highlights gut dysfunction and chronic fatigue as overlapping, clinically important issues, again supporting that these are legitimate focuses of clinical practice. The chapter on the gut‑immune‑brain axis discusses how inflammation and autoimmunity intersect with gut dysfunction, further supporting that these are standard, evidence‑based clinical domains.

Contradicts

None of the indexed papers evaluate Dr. Hart’s own practice patterns, patient volume, or outcomes, so they do not directly confirm that this specific clinician “works extensively” with these conditions. The available evidence describes disease mechanisms and management strategies for chronic fatigue, inflammation, autoimmunity, and gut dysfunction, but it does not provide data on environmentally driven illness as a distinct, well‑defined diagnostic category, nor does it validate any particular clinician’s claimed expertise or caseload. Overall, the claim about the scope and extent of Dr. Hart’s individual practice is a marketing or biographical statement rather than a directly testable scientific claim, so high‑quality evidence neither strongly supports nor contradicts it.

Mainstream view

Mainstream medical evidence recognizes inflammation, autoimmunity, chronic fatigue, gut dysfunction, and mineral imbalances as important clinical problems that are commonly addressed in primary care, internal medicine, rheumatology, gastroenterology, psychiatry, and rehabilitation settings. Systematic reviews on chronic illness and fatigue in older individuals and on fatigue self‑management confirm that chronic fatigue and related symptoms are prevalent and that structured management approaches are used across health professions. Evidence on the gut‑immune‑brain axis and gut dysbiosis indicates that gut dysfunction can be mechanistically linked to inflammation, autoimmunity, and chronic fatigue, fitting within a mainstream, research‑based framework rather than being fringe concepts. Mainstream practice also acknowledges environmental factors (such as toxins, occupational exposures, and lifestyle) as contributors to disease, but “environmentally driven illness” is not typically used as a single, unified diagnostic label; instead, specific conditions (e.g., asthma from air pollutants, occupational lung disease, heavy‑metal toxicity) are addressed individually.

In their own wordsView sourceArchived copy

“Autoimmunity”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Chronic Fatigue.

Chronic Fatigue

Supports

The indexed papers show that chronic fatigue, gut dysfunction, inflammation, and autoimmunity are recognized, prevalent clinical problems that are commonly managed by clinicians and allied health professionals, which makes it plausible that a physician could work extensively with people who have these conditions. Systematic reviews demonstrate that chronic illness and fatigue in older adults are common and require ongoing clinical management, including rehabilitation and self‑management programs, implying that clinicians routinely care for such patients. A systematic review and meta‑analysis on gut dysbiosis in severe mental illness and chronic fatigue highlights gut dysfunction and chronic fatigue as overlapping, clinically important issues, again supporting that these are legitimate focuses of clinical practice. The chapter on the gut‑immune‑brain axis discusses how inflammation and autoimmunity intersect with gut dysfunction, further supporting that these are standard, evidence‑based clinical domains.

Contradicts

None of the indexed papers evaluate Dr. Hart’s own practice patterns, patient volume, or outcomes, so they do not directly confirm that this specific clinician “works extensively” with these conditions. The available evidence describes disease mechanisms and management strategies for chronic fatigue, inflammation, autoimmunity, and gut dysfunction, but it does not provide data on environmentally driven illness as a distinct, well‑defined diagnostic category, nor does it validate any particular clinician’s claimed expertise or caseload. Overall, the claim about the scope and extent of Dr. Hart’s individual practice is a marketing or biographical statement rather than a directly testable scientific claim, so high‑quality evidence neither strongly supports nor contradicts it.

Mainstream view

Mainstream medical evidence recognizes inflammation, autoimmunity, chronic fatigue, gut dysfunction, and mineral imbalances as important clinical problems that are commonly addressed in primary care, internal medicine, rheumatology, gastroenterology, psychiatry, and rehabilitation settings. Systematic reviews on chronic illness and fatigue in older individuals and on fatigue self‑management confirm that chronic fatigue and related symptoms are prevalent and that structured management approaches are used across health professions. Evidence on the gut‑immune‑brain axis and gut dysbiosis indicates that gut dysfunction can be mechanistically linked to inflammation, autoimmunity, and chronic fatigue, fitting within a mainstream, research‑based framework rather than being fringe concepts. Mainstream practice also acknowledges environmental factors (such as toxins, occupational exposures, and lifestyle) as contributors to disease, but “environmentally driven illness” is not typically used as a single, unified diagnostic label; instead, specific conditions (e.g., asthma from air pollutants, occupational lung disease, heavy‑metal toxicity) are addressed individually.

In their own wordsView sourceArchived copy

“Chronic Fatigue”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Chronic fatigue and fibromyalgia

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Mold illness and CIRS as within their scope of practice.

Mold illness and CIRS

Supports

High-quality evidence for chiropractic treatment specifically targeting mold illness or Chronic Inflammatory Response Syndrome (CIRS) is essentially absent. ^{[5][10][9][40][41]} There are some basic science and small clinical studies suggesting that spinal manipulation can modulate inflammatory mediators and immune responses, but these focus on musculoskeletal pain (e. ^[3][2] g. , chronic low back pain) and general cytokine changes, not biotoxin-related CIRS or mold illness. The open-label and mechanistic work on CIRS supports pharmacologic, environmental, and immunologic strategies, such as the Shoemaker protocol and vasoactive intestinal peptide (VIP), as having documented clinical efficacy and biomarker changes, rather than chiropractic care. One recent review concludes that the only treatment with documented clinical efficacy for CIRS is the Shoemaker protocol, based on multiple clinical studies with objective biomarker improvements and symptom resolution. ^[6] The VIP nasal spray trial in CIRS related to water‑damaged buildings shows sustained clinical improvement and correction of inflammatory markers over 18 months. These data support CIRS as an inflammatory, immune-mediated condition that responds to targeted biotoxin-removal and neuropeptide replacement interventions, not manual spine manipulation. Overall, any support for chiropractic in this context is limited to hypothetical or adjunctive roles (e. g. , general pain relief, musculoskeletal function, possible modest modulation of inflammatory cytokines) rather than evidence-based primary treatment of mold illness or CIRS. ^[1]

Contradicts

The main contradiction is that existing peer‑reviewed literature and guidelines do not identify chiropractic care as an established or primary treatment for mold illness or CIRS. CIRS research and protocols emphasize environmental avoidance of water‑damaged buildings, use of bile acid sequestrants like cholestyramine to interrupt enterohepatic recirculation of biotoxins, dietary and pharmacologic modulation of inflammatory markers such as MMP‑9 and TGF‑β1, and, in some cases, VIP nasal spray, rather than spinal manipulation or chiropractic adjustment. ^[40] The recent narrative review of CIRS treatment explicitly finds that the Shoemaker protocol is the only documented effective therapy; it does not list chiropractic care among effective treatments, which strongly suggests that evidence for chiropractic as a direct CIRS or mold illness therapy is weak or absent. ^[7][9] VIP replacement therapy in water‑damaged building–related CIRS likewise demonstrates improvement in symptoms, inflammatory biomarkers, endocrine parameters, and cardiopulmonary function without involving chiropractic interventions, indicating that effective treatment can be achieved through non‑chiropractic medical approaches. ^[41] More broadly, mainstream clinical guidelines for inflammatory, nutritional, neurologic, and pain conditions (e. ^[3] g. , EFNS guideline for tension‑type headache, nutrition guidelines for inflammatory bowel disease and parenteral nutrition) do not position chiropractic as a disease‑modifying therapy for systemic inflammatory syndromes, underscoring that any claim that chiropractors can treat mold illness or CIRS as a primary modality is not supported by high‑quality evidence. ^{[1][2][4][6][5][10]} Instead, chiropractic efficacy is generally limited to certain musculoskeletal disorders, with little or no high‑level evidence for curing or directly treating systemic biotoxin-driven inflammation.

Mainstream view

The mainstream medical position is that Chronic Inflammatory Response Syndrome (CIRS) and mold-related illness are systemic inflammatory and immune-mediated conditions primarily managed through evidence-based medical protocols: removal from biotoxin exposure, pharmacologic binding and elimination of biotoxins (e. ^{[1][5][10][9][40]} g. , cholestyramine), management of comorbidities, and, in selected protocols, targeted therapies such as VIP nasal spray and other steps outlined in Shoemaker-style treatment algorithms. Current peer‑reviewed CIRS literature considers these medical protocols, not chiropractic manipulation, as the only documented effective treatments with objective biomarker and clinical improvements. Chiropractic care is viewed within mainstream medicine as a modality useful for certain musculoskeletal pain conditions (e. g. , low back pain, some headaches) and possibly as an adjunct for symptom relief, mobility, or general well‑being, but not as a proven, disease‑modifying treatment for systemic inflammatory syndromes like CIRS or mold illness. ^[41] Major clinical guidelines in internal medicine, neurology, and nutrition focus on pharmacologic, environmental, rehabilitative, and dietary interventions rather than chiropractic care for systemic inflammatory or toxin‑mediated diseases, reflecting a consensus that chiropractic is not an established treatment for mold illness or CIRS. ^[3][2][4]

In their own wordsView sourceArchived copy

“Mold illness and CIRS”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Mold illness and CIRS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Lyme disease and co-infections as within their scope of practice.

Lyme disease and co-infections

Supports

No high-quality evidence supports chiropractic treatment as a treatment for Lyme disease or tick-borne co-infections. The major evidence-based Lyme guidelines focus on diagnosis, antibiotic treatment, and management of complications, including coinfection with other tick-borne pathogens, and do not recommend chiropractic care as disease treatment. ^{[36][37][38][39]} The mainstream Lyme-disease literature and guideline summaries emphasize validated diagnostic testing and antimicrobial therapy rather than manipulative or structural therapies.

Contradicts

The claim is contradicted by the absence of randomized trials, systematic reviews, or major guidelines showing chiropractic treatment can eradicate Borrelia infection or treat co-infections. ^[38][39] The only index items provided are a Lyme guideline and a guideline summary, both of which describe medical diagnosis and antibiotic treatment, not chiropractic therapy. ^[36][37] Chiropractic websites and testimonials are not peer-reviewed evidence and do not establish efficacy. Evidence for persistent symptoms after treatment exists, but that does not support chiropractic as an anti-infective treatment.

Mainstream view

The mainstream medical view is that Lyme disease and tick-borne co-infections are infectious diseases treated with evidence-based antimicrobial therapy when indicated, plus supportive care for symptoms and complications. ^{[36][37][38][39]} Chiropractic may be used by some patients for nonspecific musculoskeletal pain, but it is not an established or guideline-endorsed treatment for Lyme disease itself or for eradicating co-infections.

In their own wordsView sourceArchived copy

“Lyme disease and co-infections”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Lyme disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune and immune dysregulation.

Autoimmune and immune dysregulation

Supports

High-quality evidence directly supporting the claim that chiropractic treatment can treat autoimmune diseases or clinically meaningful immune dysregulation is essentially absent. ^[6][5] A recent pragmatic randomized controlled trial reported that 12 weeks of chiropractic spinal adjustments in adults with subclinical spinal pain led to changes in physiological biomarkers (increased BDNF and IL-6, decreased TNF-α, and reduced cortisol and IFN-γ), suggesting that chiropractic care may modulate stress and inflammatory pathways at a biomarker level, but not demonstrating disease-level benefit or autoimmune treatment efficacy. ^{[2][42][43][44][45]} These findings provide only very preliminary mechanistic support that spinal manipulation might influence immune-related biomarkers, not that it treats autoimmune disease.

Contradicts

A systematic review of spinal manipulative therapy and immune/infectious outcomes found no clinical evidence that spinal manipulation was efficacious or effective in changing clinically relevant immune system outcomes, preventing infectious disease, or improving disease-specific outcomes; short-term changes in immunological biomarkers were observed, but their clinical relevance was unknown. ^[7][42][45] Global chiropractic research statements similarly conclude that there is no credible scientific evidence that chiropractic adjustments have a clinically meaningful impact on the immune system or justify claims of boosting immunity or treating systemic immune disorders. ^[43][44] Major clinical guidelines for autoimmune and immune-mediated conditions, such as inflammatory bowel disease nutrition guidelines, focus on pharmacologic therapy, nutrition support, and standard medical care rather than chiropractic manipulation, and do not recommend chiropractic as disease-modifying treatment for autoimmune pathology. ^[3][2][4] Guidance on rating evidence quality highlights that existing immune-related chiropractic studies are small, imprecise, and indirect, underscoring that current evidence is weak and insufficient to support strong clinical claims. ^[5]

Mainstream view

The mainstream medical and scientific position is that chiropractic care is an evidence-based option primarily for some musculoskeletal problems (e. ^{[5][42][43][44]} g. , certain types of back pain and possibly tension-type headache), but it is not an established or recommended treatment for autoimmune diseases or clinically significant immune dysregulation. ^[6] For autoimmune conditions (such as inflammatory bowel disease, rheumatoid arthritis, autoimmune thyroid disease, psoriasis, and others), standard care is based on immunomodulatory and anti-inflammatory medications, targeted biologics, and guideline-driven nutrition and medical management, with no role for chiropractic manipulation as a disease-modifying therapy. ^{[1][2][4][7][45]} Existing research on chiropractic and immune function shows at most short-term changes in biomarkers in generally healthy or mildly symptomatic individuals, without evidence that these changes translate into prevention, remission, or control of autoimmune disease. Consequently, professional bodies and guidelines advise that chiropractic should not be represented as a treatment for autoimmune disease or immune dysregulation, though it may be used as an adjunct for musculoskeletal symptoms in patients who also have autoimmune conditions, provided they continue appropriate medical care. ^[3]

In their own wordsView sourceArchived copy

“Autoimmune and immune dysregulation”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid and hormone imbalances.

Thyroid and hormone imbalances

Supports

Major endocrine guidelines uniformly state that primary hypothyroidism and other thyroid hormone imbalances are treated with thyroid hormone replacement (levothyroxine) and management of underlying causes, not spinal manipulation or chiropractic techniques.^[14] Clinical guidelines emphasize lab-based diagnosis (TSH, free T4) and titration of levothyroxine doses to normalize these values and relieve symptoms.^[14][18] Exercise-based interventions have some evidence as a non-pharmacologic adjunct that can modestly improve thyroid function in hypothyroid patients, but these are not chiropractic manipulations and are implemented alongside standard medical therapy.^[19] The StatPearls and major guideline summaries reiterate that hypothyroidism is a systemic endocrine disorder managed medically, with no mention of chiropractic care as a treatment modality.^[18] Overall, current high-quality evidence and guidelines support standard medical endocrine management and lifestyle adjuncts, not chiropractic treatment, for thyroid and systemic hormone imbalances.

Contradicts

The clinical practice guidelines for hypothyroidism in adults from major endocrine societies define levothyroxine monotherapy as the standard treatment and do not include chiropractic or spinal manipulation as a recognized therapy for thyroid disease.^[14][18] NICE guidance on thyroid disease assessment and management likewise recommends levothyroxine as first-line treatment for primary hypothyroidism and explicitly discusses medication options and dosing without any role for chiropractic care.^[9][16] These guidelines are based on systematic reviews and large bodies of evidence; the absence of chiropractic in them reflects a lack of robust data that spinal manipulation can correct thyroid or broader hormone imbalances.^[14][18] Available chiropractic reports linking care to reduced need for thyroid medication are limited to case reports and non-randomized observations, which are very low-quality evidence and cannot establish causality; no completed randomized trials show that chiropractic treatment normalizes thyroid function or hormone profiles in hypothyroid or other endocrine patients.^[21] Thus, the influencer’s claim is contradicted by mainstream guideline-based management pathways and by the lack of high-quality clinical trials supporting chiropractic as a hormone therapy.

Mainstream view

The mainstream medical and scientific position is that thyroid and most hormone imbalances are systemic endocrine conditions that should be diagnosed and managed with evidence-based medical therapy, primarily appropriate hormone replacement (such as levothyroxine for hypothyroidism) and targeted treatment of underlying causes.^[14][18] Major guidelines from endocrine societies and organizations such as NICE do not recognize chiropractic or spinal manipulation as treatments for hypothyroidism, hyperthyroidism, or other hormone disorders, and they make no recommendations for chiropractic in this context.^{[9][14][16][18]} Non-pharmacologic adjuncts such as structured exercise programs and general lifestyle measures may support overall health and modestly improve thyroid function when combined with standard therapy, but they are not substitutes for appropriate endocrine management.^[19] In mainstream practice, chiropractors may appropriately manage musculoskeletal complaints, but thyroid and hormone imbalances are managed by primary care and endocrinology using laboratory-guided pharmacologic treatment and follow-up.^[14][18]

In their own wordsView sourceArchived copy

“Thyroid and hormone imbalances”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Hormone imbalance and replacement

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Chronic fatigue and low energy.

Chronic fatigue and low energy

Supports

High-quality evidence specifically testing chiropractic treatment for chronic fatigue syndrome or chronic low energy is essentially absent. Available academic and guideline literature focuses on other interventions (cognitive‑behavioural therapy, graded or paced physical activity, pharmacologic or nutritional approaches, and symptom management) rather than chiropractic spinal manipulation. Large randomized trials and systematic reviews show that various non‑chiropractic interventions (e.g., CBT, physical activity programs, acupuncture, herbal formulas, supplements) can produce modest improvements in fatigue and function in chronic fatigue syndrome or chronic conditions associated with fatigue, but these do not involve chiropractic care.^{[11][20][21][22][18][19]} Some small, uncontrolled chiropractic case reports and prospective series suggest possible improvement in quality of life or fatigue in individual patients with chronic fatigue, but these are anecdotal, lack control groups, and are not high‑quality evidence; they therefore provide only hypothesis‑generating support rather than robust confirmation. Overall, there is no systematic review, major guideline, or adequately powered RCT demonstrating that chiropractic treatment reliably improves chronic fatigue or low energy in the general population.

Contradicts

Major clinical guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) emphasize diagnosis, energy management/pacing, individualized activity plans, psychological support, and management of co‑morbidities; they do not recommend chiropractic manipulation as a standard or evidence‑based treatment for chronic fatigue or low energy.^[13] Systematic reviews of randomized trials in ME/CFS and in fatigue associated with chronic conditions conclude that, although some interventions such as CBT, graded or structured physical activity, and certain complementary approaches may have modest benefit, there is no single definitive, reproducible cure and many interventions show limited or inconsistent effects, highlighting the overall weakness of the evidence base.^[9][11][20] The absence of chiropractic in these reviews and guidelines indicates a lack of supportive data rather than active recommendation. Moreover, the concept of treating chronic fatigue or low energy by spinal manipulation is not grounded in the pathophysiology described in mainstream ME/CFS and fatigue research, which instead emphasizes neuroimmune, autonomic, metabolic, and psychosocial factors. Thus, the influencer’s suggestion that chiropractic treatment is an evidence‑based or primary therapy for chronic fatigue is contradicted by the current guideline‑driven and trial‑based literature, which either does not mention it or implicitly deprioritizes it in favor of better‑studied approaches.^[13][9]

Mainstream view

The mainstream medical position is that chronic fatigue and ME/CFS are complex, multifactorial conditions with unclear etiology and no single proven curative treatment.^[9][13] Management is typically multimodal and may include: careful diagnosis and exclusion of other medical causes; education about the illness; activity and energy management (often pacing rather than aggressive graded exercise); addressing sleep, pain, mood, and autonomic symptoms; and, in some cases, structured psychological or physical activity interventions such as CBT or tailored exercise programs.^{[8][10][11][20]} Nutritional or complementary interventions (e.g., CoQ10 plus NADH, herbal formulas, acupuncture, moxibustion) have emerging but still limited evidence and are considered experimental or adjunctive rather than definitive therapies.^[18][19][22] Chiropractic spinal manipulation is not a standard or guideline‑recommended treatment for chronic fatigue or low energy, and high‑quality evidence supporting its efficacy is lacking; at most, it may be used for co‑existing musculoskeletal pain, not as a primary therapy for fatigue itself. Overall, mainstream practice treats chiropractic for chronic fatigue as unproven and secondary, with priority given to interventions supported by randomized trials and guidelines.^[9][11][13]

In their own wordsView sourceArchived copy

“Chronic fatigue and low energy”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Chronic fatigue and fibromyalgia

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Gut disorders - SIBO/SIFO.

Gut disorders - SIBO/SIFO

Supports

There is limited low-quality evidence that manual therapies targeting the spine or viscera may improve symptoms in some functional gut disorders, mainly irritable bowel syndrome (IBS), but this evidence is primarily for osteopathic or visceral manipulative therapy rather than chiropractic care and does not specifically address SIBO or SIFO. ^{[5][7][53][55]} Randomized controlled trials and systematic reviews of osteopathic manipulative treatment (OMT) and visceral osteopathy in adults with IBS report statistically significant short‑term improvements in abdominal pain, distension, and some bowel habit parameters compared with sham or standard care, with generally minor or no serious adverse effects reported. ^[6] These trials and meta-analyses conclude that manipulative therapies may be promising complementary options in IBS but emphasize that evidence quality is low and sample sizes are small. Narrative and feasibility studies on chiropractic care for gastrointestinal conditions suggest possible associations between spinal manipulation and improvements in GI symptoms, but the data are based largely on case reports, uncontrolled clinical trials, or pilot studies and are considered hypothesis‑generating rather than definitive. ^[3][54] Overall, high‑quality evidence supporting chiropractic treatment as a primary or disease‑modifying therapy for gut disorders is weak; any support is indirect, focused on IBS rather than SIBO/SIFO, and typically positions manual therapy as an adjunct to conventional care. ^[56]

Contradicts

Systematic reviews specifically examining chiropractic treatment for gastrointestinal disorders have concluded that there is no supportive evidence that chiropractic is effective for GI conditions, noting that the few available trials are small and have serious methodological flaws. ^{[6][53][54][55][56]} A narrative review summarizing these findings similarly states that current scientific evidence does not demonstrate efficacy of chiropractic care in treating gastrointestinal problems and highlights that reported trials on conditions such as gastroesophageal reflux and duodenal ulcer show no significant benefit over control interventions. These higher-level reviews directly contradict claims that chiropractic manipulation is an evidence‑based treatment for gut disorders. ^[1] Moreover, no randomized controlled trials or major guidelines currently support chiropractic care as a treatment for SIBO or SIFO specifically; the standard evidence base for SIBO/SIFO focuses on antibiotic therapy (e. ^[3][5][7] g. , rifaximin), dietary strategies, and probiotic or microbiome‑modulating approaches, not spinal manipulation. The lack of disease-specific trials, the negative conclusion of systematic reviews on chiropractic for GI disorders, and the reliance on anecdotal or uncontrolled data indicate that the claim is not supported by robust evidence and may overstate both efficacy and scope.

Mainstream view

Mainstream gastroenterology and internal medicine consider SIBO and SIFO to be microbial overgrowth disorders primarily managed with evidence‑based pharmacological and dietary interventions (such as non‑absorbable antibiotics like rifaximin, targeted probiotics, and low‑FODMAP or other structured diets) and investigation of underlying motility or anatomical abnormalities. ^[1] For functional gut disorders such as IBS, major guidelines and high‑quality trials prioritize dietary modification, pharmacotherapy, psychological therapies, and microbiome‑targeted treatments, with some emerging evidence for complementary modalities such as acupuncture or osteopathic manipulative therapy, but these remain adjunctive and are not first‑line. ^[3][7] Chiropractic treatment is not recommended in major GI or nutrition guidelines for the management of IBS, SIBO, or SIFO and is generally viewed—where discussed at all—as an alternative/complementary practice lacking sufficient high‑quality evidence for routine use in these conditions. ^{[6][4][5][53][54][55][56]} The mainstream position is that chiropractic care should not replace established diagnostic work‑up and guideline‑directed therapy for gut disorders and, if used, should be considered experimental, adjunctive, and undertaken with clear communication about the limited evidence base.

In their own wordsView sourceArchived copy

“Gut disorders - SIBO/SIFO”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising IBS, SIBO and gut disorders

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Pediatric PANS and PANDAS.

Pediatric PANS and PANDAS

Supports

There are currently no randomized controlled trials, systematic reviews, or major clinical guidelines that specifically support chiropractic treatment as an effective therapy for pediatric PANS or PANDAS. ^{[3][7][58][59]} Available high‑quality guidance documents and consensus statements for PANS/PANDAS instead emphasize a combination of antibiotics, anti‑inflammatory or immunomodulatory therapy, and evidence‑based psychiatric and behavioral interventions as the core of care, not chiropractic manipulation. ^{[1][5][57][60]} Contemporary narrative and guideline‑style reviews describe PANDAS/PANS as autoimmune/neuropsychiatric syndromes triggered by infection, with management frameworks built around infection control, immunology, and psychiatric care rather than manual therapies. Case reports and small series in chiropractic literature describe benefits for musculoskeletal and pain conditions, but these involve different adult populations (e. g. , failed back surgery syndrome, lumbar spine disorders) and cannot be extrapolated to pediatric autoimmune neuropsychiatric syndromes.

Contradicts

Consensus clinical management papers and guideline documents for PANS/PANDAS consistently recommend a structured medical approach: accurate diagnostic work‑up, antibiotic treatment of streptococcal or other infections when present, short courses of non‑steroidal anti‑inflammatory drugs or steroids, immunomodulatory therapies such as IVIG or plasma exchange in severe, selected cases, and psychiatric care including cognitive‑behavioral therapy and appropriate psychopharmacology. ^{[1][3][2][4][6][7][57][58][59]} These sources do not include chiropractic therapy as a recommended or evidence‑based treatment modality for PANS or PANDAS and instead stress an interdisciplinary team of pediatricians, immunologists, neurologists, and mental health professionals. Recent reviews emphasize that PANDAS/PANS remain diagnoses of exclusion with significant diagnostic uncertainty, and they warn that unproven interventions can expose children to risk while delaying established treatments. The available chiropractic outcome data relate to adult spine pain (including studies evaluating risk of cauda equina syndrome or outcomes in failed back surgery syndrome) and do not address autoimmune neuropsychiatric disorders in children, highlighting a mismatch between the influencer’s claim and the evidence base. ^[5][60]

Mainstream view

The mainstream medical and scientific position is that pediatric PANS and PANDAS should be managed using evidence‑based medical and psychiatric strategies focused on: (1) confirming the diagnosis and ruling out other causes; (2) treating documented infections with appropriate antibiotics; (3) using anti‑inflammatory and, in selected severe cases, immunomodulatory therapies; and (4) providing structured psychiatric and behavioral care, especially cognitive‑behavioral therapy and appropriate pharmacologic treatment. ^{[4][6][5][7][57][58][60]} Major guidance documents and expert panels do not recognize chiropractic treatment as a validated or recommended therapy for these conditions. Chiropractic care may be used by some families as a general wellness or adjunctive musculoskeletal intervention, but this is outside guideline‑supported PANS/PANDAS management and lacks high‑quality evidence for disease modification or symptom control in these pediatric autoimmune neuropsychiatric syndromes. ^[1][2][59]

In their own wordsView sourceArchived copy

“Pediatric PANS and PANDAS”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising PANS and PANDAS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise What Is Mold Illness (CIRS)? as within their scope of practice.

What Is Mold Illness (CIRS)?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“What Is Mold Illness (CIRS)?”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise What Is Lyme Disease? as within their scope of practice.

What Is Lyme Disease?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“What Is Lyme Disease?”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Meet Our Mold-Literate & Lyme-Literate Practitioners as within their scope of practice.

Meet Our Mold-Literate & Lyme-Literate Practitioners

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Meet Our Mold-Literate & Lyme-Literate Practitioners”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Lyme disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune.

Autoimmune

Supports

High-quality evidence directly supporting the claim that chiropractic treatment can treat autoimmune diseases or clinically meaningful immune dysregulation is essentially absent. ^[6][5] A recent pragmatic randomized controlled trial reported that 12 weeks of chiropractic spinal adjustments in adults with subclinical spinal pain led to changes in physiological biomarkers (increased BDNF and IL-6, decreased TNF-α, and reduced cortisol and IFN-γ), suggesting that chiropractic care may modulate stress and inflammatory pathways at a biomarker level, but not demonstrating disease-level benefit or autoimmune treatment efficacy. ^{[2][42][43][44][45]} These findings provide only very preliminary mechanistic support that spinal manipulation might influence immune-related biomarkers, not that it treats autoimmune disease.

Contradicts

A systematic review of spinal manipulative therapy and immune/infectious outcomes found no clinical evidence that spinal manipulation was efficacious or effective in changing clinically relevant immune system outcomes, preventing infectious disease, or improving disease-specific outcomes; short-term changes in immunological biomarkers were observed, but their clinical relevance was unknown. ^[7][42][45] Global chiropractic research statements similarly conclude that there is no credible scientific evidence that chiropractic adjustments have a clinically meaningful impact on the immune system or justify claims of boosting immunity or treating systemic immune disorders. ^[43][44] Major clinical guidelines for autoimmune and immune-mediated conditions, such as inflammatory bowel disease nutrition guidelines, focus on pharmacologic therapy, nutrition support, and standard medical care rather than chiropractic manipulation, and do not recommend chiropractic as disease-modifying treatment for autoimmune pathology. ^[3][2][4] Guidance on rating evidence quality highlights that existing immune-related chiropractic studies are small, imprecise, and indirect, underscoring that current evidence is weak and insufficient to support strong clinical claims. ^[5]

Mainstream view

The mainstream medical and scientific position is that chiropractic care is an evidence-based option primarily for some musculoskeletal problems (e. ^{[5][42][43][44]} g. , certain types of back pain and possibly tension-type headache), but it is not an established or recommended treatment for autoimmune diseases or clinically significant immune dysregulation. ^[6] For autoimmune conditions (such as inflammatory bowel disease, rheumatoid arthritis, autoimmune thyroid disease, psoriasis, and others), standard care is based on immunomodulatory and anti-inflammatory medications, targeted biologics, and guideline-driven nutrition and medical management, with no role for chiropractic manipulation as a disease-modifying therapy. ^{[1][2][4][7][45]} Existing research on chiropractic and immune function shows at most short-term changes in biomarkers in generally healthy or mildly symptomatic individuals, without evidence that these changes translate into prevention, remission, or control of autoimmune disease. Consequently, professional bodies and guidelines advise that chiropractic should not be represented as a treatment for autoimmune disease or immune dysregulation, though it may be used as an adjunct for musculoskeletal symptoms in patients who also have autoimmune conditions, provided they continue appropriate medical care. ^[3]

In their own wordsView sourceArchived copy

“Autoimmune”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Autoimmune disease

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise Mold and CIRS Related Illness as within their scope of practice.

Mold and CIRS Related Illness

Supports

There is essentially no high-quality evidence (systematic reviews, RCTs, major guidelines) showing that chiropractic spinal manipulation or typical chiropractic modalities can treat mold-related illness or Chronic Inflammatory Response Syndrome (CIRS). CIRS itself has emerging but still limited evidence base focused on environmental control and pharmacologic/medical protocols, notably the Shoemaker-type biotoxin protocols (stepwise removal from exposure, bile-acid sequestrant binders such as cholestyramine/Welchol, treatment of MARCoNS, correction of specific inflammatory and hormonal biomarkers, and VIP therapy), not manual therapy. Narrative and literature reviews of CIRS treatment identify the Shoemaker protocol as the only approach with documented clinical efficacy in the published literature, and these are medical, environmental and pharmacologic interventions rather than chiropractic ones.^[19] A recent comprehensive review of CIRS pathophysiology and biomarkers similarly describes immune and transcriptomic abnormalities and discusses treatment using the Shoemaker framework, again without reference to chiropractic or spinal manipulation as a disease-modifying therapy.^[18][11][20] Case-type and observational reports exploring adjunctive therapies in CIRS (e.g., low-pressure hyperbaric oxygen therapy) still treat CIRS as an inflammatory, multi-system illness managed through medical and environmental approaches, not chiropractic care.^[16] The index guidelines provided (on hypertension management, parenteral nutrition, IBD nutrition, headache treatment, blood transfusion, colchicine in pericarditis, and GRADE methodology) exemplify mainstream evidence-based practice and do not mention chiropractic as a primary therapy for systemic inflammatory or toxic exposures, indirectly reinforcing that chiropractic is not part of guideline-driven management for systemic inflammatory syndromes or toxin-related illnesses.

Contradicts

Current CIRS-focused reviews emphasize that the diagnosis is controversial, the evidence base is limited, and standardized guidelines or broad consensus are lacking, which already weakens any strong claim that specific non-medical modalities such as chiropractic treatment can reliably treat CIRS or mold-related illness.^[17][18] The review of treatment efficacy for CIRS finds that only the Shoemaker protocol has documented benefit, and even this is based on small, largely uncontrolled studies and observational data, underscoring that evidence is modest and closely tied to environmental and pharmacologic management rather than manual therapies.^[19] Available clinical pathways and policy documents dealing with biotoxin or mold-related illness focus on exposure avoidance, environmental remediation, symptom-directed medical care, and referral to appropriate medical specialists, not chiropractic manipulation.^[3][4][10] The literature describing CIRS notes overlapping symptomatology with conditions like ME/CFS and sick building syndrome and highlights considerable diagnostic and therapeutic uncertainty; under such circumstances, claims that chiropractic care can specifically treat the underlying pathophysiology of mold/CIRS go beyond the data and are unsupported by peer-reviewed trials or guidelines.^[17][18][19] Mainstream guidelines in other inflammatory and systemic conditions (e.g., hypertension, pericarditis, critical illness nutrition, headache) set a standard for how evidence-based therapies are incorporated into practice and do not include chiropractic manipulation as a treatment for systemic inflammatory response or toxin-mediated syndromes, indirectly contradicting any assertion that such use is established or evidence-based.

Mainstream view

Mainstream medicine currently views CIRS and mold-related illness as emerging, controversial diagnostic constructs with some biological plausibility but limited high-quality evidence and no universally accepted diagnostic or treatment guidelines.^[17][18] Where CIRS is considered, mainstream or near-mainstream practice focuses on: removal from ongoing exposure to damp/moldy environments; environmental testing and remediation when appropriate; symptom-directed conventional medical care; and, in some specialized centers, use of structured medical protocols involving bile-acid sequestrant binders, treatment of nasal MARCoNS, and targeted correction of inflammatory and endocrine biomarkers.^[11][19][20] Chiropractic care may be used in general practice as supportive management for musculoskeletal pain or functional complaints but is not recognized in major guidelines or systematic reviews as a disease-modifying treatment for mold toxicity, biotoxin illness, or CIRS itself. No large RCTs, meta-analyses, or authoritative guidelines recommend chiropractic spinal manipulation to treat the underlying immunologic or toxicologic mechanisms of mold-related illness or CIRS. Standard evidence-based methodology (as reflected in GRADE and other clinical guidelines) would classify such claims as very low-quality or unsubstantiated because of the absence of direct trials, mechanistic support, and reproducible clinical outcome data.[ref:

In their own wordsView sourceArchived copy

“Mold and CIRS Related Illness”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Mold illness and CIRS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure mold illness.

mold illness

Supports

There is emerging peer-reviewed literature describing Chronic Inflammatory Response Syndrome (CIRS) as an acquired medical condition characterized by innate immune dysregulation following environmental exposure, including mold and other biotoxins, with multi‑system involvement. ^[10] A 2015 transcriptomic study of patients who developed CIRS after ciguatoxin exposure found distinct gene expression patterns separating cases from controls and highlighted disruption of innate and adaptive immune mechanisms, supporting that at least one form of CIRS is a chronic inflammatory, multi‑system response to a specific biotoxin exposure. Recent review articles and case reports (outside the provided index list) describe CIRS related to water‑damaged buildings and mold as a complex, multi‑symptom condition attributed to biotoxins and inflammagens, again supporting that the concept exists in the peer‑reviewed literature as a chronic inflammatory response to molds and other environmental biotoxins. ^[9] Overall, these sources support that a chronic, multi‑system inflammatory syndrome after certain biotoxin exposures has been described and studied, lending some support to the general framing of CIRS as a complex, multi‑system condition triggered by mold and biotoxins.

Contradicts

Major high‑quality evidence sources and guidelines in the provided index list do not address CIRS or “mold illness” at all, which means there is no guideline‑level endorsement of CIRS as a well‑established disease entity. ^[5][9] The hypertension guideline update, ESPEN and ASPEN‑FELANPE nutrition guidelines, parenteral nutrition appropriateness statement, EFNS tension‑type headache guideline, blood transfusion therapy review, pleural effusion diagnostic approach, and GRADE imprecision paper all focus on other conditions and do not recognize or discuss CIRS or mold illness. ^{[1][2][3][4][6][7][8][10]} This absence in major guidelines and methodological standards underscores that the evidence base for CIRS is still limited and not integrated into mainstream clinical frameworks. In addition, available CIRS literature relies heavily on observational data, case series, and single‑center cohorts, often from a small group of proponents, with very few or no independent randomized controlled trials, which weakens the strength of evidence for causality and for the broad claim that CIRS is a well‑defined, common, multi‑system condition from mold and other biotoxins. Some mainstream reviews of indoor air quality and sick building syndrome characterize symptoms after building‑related exposures as multifactorial, with psychological, ergonomic, and general environmental contributors, rather than a single, unified biotoxin‑driven inflammatory syndrome. This body of evidence and the lack of major guideline recognition contradict the strong, categorical framing of mold illness/CIRS as a clearly established complex multi‑system disease with a well‑validated pathophysiology and diagnostic criteria.

Mainstream view

The mainstream medical position is that exposure to dampness and mold can contribute to respiratory symptoms (such as asthma exacerbations, allergic rhinitis, and hypersensitivity pneumonitis) and sometimes to poorly specific symptoms, but that a distinct, universally accepted entity called Chronic Inflammatory Response Syndrome (CIRS) or “mold illness” is not yet established in major clinical guidelines or consensus documents. ^{[2][3][5][9][10]} Conventional allergology, pulmonology, and occupational medicine recognize mold‑related disease primarily in terms of allergic and immunologic conditions with defined diagnostic criteria (IgE‑mediated allergy, hypersensitivity pneumonitis, fungal infections) rather than a single chronic multi‑system inflammatory syndrome driven by biotoxins. Research such as the ciguatoxin‑induced CIRS transcriptomic study supports that chronic inflammatory responses with multi‑system involvement can occur after specific biotoxin exposures and that the term CIRS is used in the scientific literature in that context. However, the broader concept promoted by influencers—that mold and diverse biotoxins commonly cause a unified, well‑characterized syndrome affecting many organ systems and explain a wide range of chronic illnesses—remains controversial. Major bodies have not endorsed standardized diagnostic criteria or treatment protocols for CIRS, and the evidence is considered preliminary, with calls for larger, independent, rigorously designed studies before CIRS can be accepted as a distinct, widely recognized clinical entity. ^[6]

In their own wordsView sourceArchived copy

“mold illness”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

See every doc bro advertising Mold illness and CIRS

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to advertise We use comprehensive, evidence-informed functional labs to uncover hidden imbalances and underlying drivers of chronic symptoms. as within their scope of practice.

We use comprehensive, evidence-informed functional labs to uncover hidden imbalances and underlying drivers of chronic symptoms.

Supports

Major clinical guidelines across conventional medicine endorse using appropriate laboratory tests to support diagnosis and management of chronic diseases when guided by clinical history, exam, and validated indications. ^{[3][4][63][65]} Evidence-based frameworks such as GRADE emphasize that lab-based decisions should rely on high-quality evidence and explicit assessment of imprecision and other biases. ^[1][5][64] In areas like hypertension, inflammatory bowel disease, and clinical nutrition, guidelines show that targeted, guideline-aligned testing can clarify disease status and guide treatment, which indirectly supports the idea that labs can reveal clinically relevant abnormalities contributing to chronic symptoms when used appropriately. ^{[2][6][62][66]}

Contradicts

The specific notion of “comprehensive functional labs” designed to uncover “hidden imbalances” and “underlying drivers of chronic symptoms” as promoted in functional medicine is not supported by major guidelines or high-quality trials, and is largely absent from the indexed guideline literature. ^[3][6][5] High-quality evidence and meta-analyses highlight substantial overuse and inappropriate utilization of diagnostic and laboratory testing, showing that a significant proportion of tests are low-value and do not improve patient outcomes, which directly contradicts the blanket implication that more comprehensive testing is inherently beneficial. ^{[63][64][65][66]} Evidence-based discussions of nutrition support, headache treatment, blood transfusion, and laser therapy for knee osteoarthritis all stress targeted, indication-based testing and interventions, not broad exploratory panels to search for occult imbalances. ^{[1][4][7][62]}

Mainstream view

The mainstream medical position is that laboratory testing should be used judiciously, driven by a clear clinical question, guideline-based indications, and an evidence-based framework such as GRADE to balance benefits, harms, and cost. ^{[1][6][5][62][63][64][65][66]} Guidelines for hypertension, clinical nutrition (including parenteral nutrition and inflammatory bowel disease), headache, transfusion therapy, and other conditions consistently endorse targeted, condition-specific tests rather than broad, non-specific “comprehensive” panels aimed at uncovering unvalidated imbalances. ^[3][2][4][7] Mainstream practice acknowledges that poorly indicated testing can cause harm through false positives, unnecessary follow-up, and resource waste, and therefore emphasizes test stewardship and avoidance of low-value testing.

In their own wordsView sourceArchived copy

“We use comprehensive, evidence-informed functional labs to uncover hidden imbalances and underlying drivers of chronic symptoms.”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not approved to offer Dr. Hart and Dr. Aoki will discuss what can be done based on lab work, biofeedback testing and honest communication, and clinical expertise to determine a path that fits your healthcare starting tomorrow. within a Chiropractor scope of practice under Tennessee Board of Chiropractic Examiners.

Dr. Hart and Dr. Aoki will discuss what can be done based on lab work, biofeedback testing and honest communication, and clinical expertise to determine a path that fits your healthcare starting tomorrow.

Supports

The influencer’s claim is extremely general: that clinicians can use lab work, biofeedback testing, honest communication, and clinical expertise to determine a path that fits a patient’s healthcare starting tomorrow. At a high level, mainstream guidelines across multiple areas of medicine do support using laboratory data and clinical expertise to tailor management plans. ^[3] For example, guideline‑driven management of hypertension emphasizes using objective measurements (blood pressure, lab parameters), guideline recommendations, and clinical judgment to individualize treatment. ^[1][6][67] Clinical nutrition guidelines for inflammatory bowel disease similarly advocate integrating laboratory findings, disease activity, patient preferences, and clinician expertise to choose appropriate nutrition strategies. ^[2] Parenteral nutrition guidelines stress using lab work, clinical status, and expert judgment to decide when nutrition support is appropriate. ^[4] Blood transfusion practice also relies on lab values (e. ^[7] g. , hemoglobin, coagulation profiles) and clinician assessment to make individualized transfusion decisions. Communication with patients to incorporate values and preferences is an accepted component of guideline-based care and the GRADE framework emphasizes shared decision making based on evidence quality and patient priorities. ^[5]

Contradicts

None of the cited index papers specifically endorse or evaluate “biofeedback testing” as a standard, broadly applicable tool for determining a personalized care path across conditions. Major guidelines instead focus on validated diagnostics (labs, imaging, clinical examination) and structured evidence grading, not generic biofeedback approaches, and they do not support the notion that simply combining lab work, biofeedback, communication, and expertise guarantees an appropriate care path starting immediately. ^[3] The claim suggests a very broad, near‑universal applicability and immediacy (“starting tomorrow”) that is not reflected in high‑quality evidence or guidelines, which stress condition‑specific criteria, stepwise evaluation, and sometimes prolonged assessment. ^[5] The listed guidelines also do not support the idea that biofeedback testing is a core component of care for hypertension, clinical nutrition, parenteral nutrition, tension‑type headache, transfusion therapy, or neonatal hypoxic‑ischemic encephalopathy. ^{[2][4][6][7][67]}

Mainstream view

Mainstream medical practice supports using objective data (lab work and other diagnostics), patient‑clinician communication, and clinical expertise to formulate individualized care plans, but in a condition‑specific, guideline‑driven, and evidence‑based manner. ^[1][2] Shared decision making based on high‑quality evidence, graded with frameworks such as GRADE, and patient preferences is widely endorsed. ^[5] However, biofeedback testing is not a universal or foundational tool across all medical conditions; its use is limited to specific indications, and major guidelines for hypertension, clinical nutrition, parenteral nutrition, tension‑type headache, transfusion therapy, and hypoxic‑ischemic encephalopathy do not treat it as a general pillar of care. ^{[3][4][6][7][67]} Mainstream evidence therefore supports the general idea of individualized care using labs, communication, and expertise, but not the broad, unspecified promise that such an approach, including biofeedback, can immediately determine a suitable path for any person’s healthcare starting tomorrow.

In their own wordsView sourceArchived copy

“Dr. Hart and Dr. Aoki will discuss what can be done based on lab work, biofeedback testing and honest communication, and clinical expertise to determine a path that fits your healthcare starting tomorrow.”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Functional root-cause care.

Functional root-cause care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Functional root-cause care”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Intensive functional root-cause program.

Intensive functional root-cause program

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Intensive functional root-cause program”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Complex chronic illness.

Complex chronic illness

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Complex chronic illness”

Rule: T.C.A. § 63-4-101(a)(2)-(3)

Martin Hart is not licensed or approved by Tennessee Board of Chiropractic Examiners to diagnose, treat, or cure Functional care.

Functional care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Functional care”

Rule: Tennessee Chiropractic Practice Act (scope limited to musculoskeletal/spine care)